Displaying 21 - 40 of 699
Statement of Chair Lina M. Khan Joined by Commissioners Alvaro M. Bedoya & Rebecca Kelly Slaughter Regarding the Pharmacy Benefit Managers Interim Staff Report
FTC Releases Interim Staff Report on Prescription Drug Middlemen
Statement Regarding the Termination of Novant Health’s Acquisition of Hospitals from Community Health Systems
Statement of Chair Lina M. Khan in the Matter of Exxon Mobil Corporation
Concurring Statement of Commissioner Rebecca Kelly Slaughter in the Matter of ExxonMobil Corp
Concurring Statement of Commissioner Alvaro M. Bedoya in the Matter of ExxonMobil Co./Pioneer Natural Resource Co.
Joint Dissenting Statement of Commissioners Melissa Holyoak and Andrew N. Ferguson in the Matter of Exxon Mobil Corporation
IQVIA Holdings/Propel Media, In the Matter of
On July 17, 2023, the Federal Trade Commission sued to block IQVIA Holdings Inc. (IQVIA) from acquiring Propel Media, Inc. (PMI), alleging in an administrative complaint that the proposed acquisition would give IQVIA a market- leading position in programmatic advertising for health care products, namely prescription drugs, to doctors and other health care professionals. The Commission also authorized FTC staff to seek a temporary restraining order and preliminary injunction in federal district court to prevent IQVIA from consummating its acquisition of PMI, pending the agency’s administrative proceeding.
After a nearly two-week evidentiary hearing and closing arguments in late November and December 2023, U.S. District Court Judge Edgardo Ramos issued an order granting the FTC’s motion for preliminary injunction on December 29, 2023.
FTC and DOJ Update Guidance That Reinforces Parties’ Preservation Obligations for Collaboration Tools and Ephemeral Messaging
FTC Announces 2024 Update of Size of Transaction Thresholds for Premerger Notification Filings
Statement on FTC Win Securing Temporary Block of IQVIA’s Acquisition of Propel Media
Statement of Chair Lina M. Khan Joined by Commissioner Rebecca Kelly Slaughter and Commissioner Alvaro M. Bedoya Regarding the FY2022 HSR Annual Report to Congress
FTC, DOJ Issue Fiscal Year 2022 Hart-Scott-Rodino Notification Report
John Muir Health/Tenet Healthcare Co., In the Matter of
The Federal Trade Commission sued to block John Muir Health’s proposed $142.5 million deal to acquire sole ownership of San Ramon Regional Medical Center, LLC from current majority owner Tenet Healthcare Corporation, saying the deal will drive up health care costs.
The Commission issued an administrative complaint and authorized a lawsuit in federal court alleging the proposed acquisition will eliminate head-to-head competition between John Muir Health and nearby San Ramon Regional Medical Center.
On December 18, 2023 the FTC and California moved to dismiss their federal court case and the FTC dismissed its administrative challenge following John Muir announcing it would terminate its proposed deal to acquire Tenet’s remaining interest in San Ramon Medical Center.
Displaying 21 - 40 of 699